Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xencor Inc (XNCR)

Xencor Inc (XNCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xencor Inc 465 NORTH HALSTEAD STREET SUITE 200 PASADENA CA 91107 USA

www.xencor.com Employees: 250 P: 626-305-5900

Sector:

Medical

Description:

Xencor Inc. is a clinical-stage biopharmaceutical company. It develops antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Xencor Inc. is based in Monrovia, California.

Key Statistics

Overview:

Market Capitalization, $K 1,120,423
Enterprise Value, $K 1,243,153
Shares Outstanding, K 71,410
Annual Sales, $ 110,490 K
Annual Net Income, $ -232,620 K
Last Quarter Sales, $ 21,000 K
Last Quarter Net Income, $ -6,030 K
EBIT, $ -119,820 K
EBITDA, $ -121,430 K
60-Month Beta 0.96
% of Insider Shareholders 4.76%
Float, K 68,011
% Float 95.24%
Short Interest 8,891
Short Float 12.45%
Short Volume Ratio 0.28

Growth:

1-Year Return -35.24%
3-Year Return -39.89%
5-Year Return -65.95%
5-Year Revenue Growth -29.49%
5-Year Earnings Growth -878.26%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 11/05/25
Next Earnings Date 02/26/26
Earnings Per Share ttm -1.77
EPS Growth vs. Prev Qtr 80.49%
EPS Growth vs. Prev Year 88.73%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

XNCR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -20.44%
Return-on-Assets % -14.52%
Profit Margin % -210.53%
Debt/Equity 0.00
Price/Sales 10.21
Price/Cash Flow N/A
Price/Book 1.80
Book Value/Share 8.76
Interest Coverage -5.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar